HAI Guang-fan1, YANG Jun1, ZHANG He-ming1, et al. Patent Analysis of Plant Extracts,Chinese Herbal Drug and Chinese Patent Medicines in China,Korea,Germany,Japan and USA from 2006 to 2010[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(15): 274-277.
HAI Guang-fan1, YANG Jun1, ZHANG He-ming1, et al. Patent Analysis of Plant Extracts,Chinese Herbal Drug and Chinese Patent Medicines in China,Korea,Germany,Japan and USA from 2006 to 2010[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(15): 274-277. DOI: 10.13422/j.cnki.syfjx.2011.15.084.
Patent Analysis of Plant Extracts,Chinese Herbal Drug and Chinese Patent Medicines in China,Korea,Germany,Japan and USA from 2006 to 2010
Objective:Depending on the patent application numbers of plant extracts
Chinese herbal drugs and Chinese patent medicines in China
Korea
Germany
Japan and USA from 2006 to 2010
the data were analyzed about their developing tends and to estimate consciousness of intellectual property rights.Method:Patent numbers of plant extracts
Chinese herbal drugs and Chinese patent medicines in China
Korea
Germany
Japan and USA from 2006 to 2010 were obtained from official webs in China
Korea
Germany
Japan and USA.Result:The results showed that the numbers of plant extracts
Chinese herbal drugs and Chinese patent medicines were going down in China
Korea
Germany
Japan and USA
while for the patent application number of plant extracts
Korea was first most and China was second;The patent application of Chinese herbal drugs was not so much
in which China was first most and Korea second.For the patent application number of Chinese patent medicines
China is the much more than the other countries.Conclusion:The R&D for Chinese traditional medicines has been shown to slip down.For the total patent application number of Chinese traditional medicines
China was much higher than the other countries
whereas the other countries special Korea were also developed.Oppositely protection of intellectual property rights of Chinese traditional medicines should be strengthened further.More R&D should be invested in Chinese traditional medicines.
Formulation Characteristics and Efficacy Classification of Chinese Patent Medicines for Cardiovascular and Cerebrovascular Diseases Based on Diagram of Tangye Jingfa Tu
Correlation of "Medicinal Tissue-property, Taste, and Efficacy-clinical Application" of Traditional Chinese Medicine from Plant Skin
Construction of Evidence Body for Revision of Safety Information on Package Inserts of Chinese Patent Medicines in Post-marketing: Taking Xiaoke'an Capsules as an Example
Application and Analysis of High-quality Evaluation for Jianwei Xiaoshi Tablets
Related Author
HAI Guang-fan
YANG Jun
ZHANG He-ming
PAN Yan-juan
LU Guang-zhou
CHEN Feng
LI Si-jia
YAN Fu-lin
Related Institution
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Xuanwu Hospital, Capital Medical University
Community Health Center, Beijing Jiaotong University
Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-yao
Henan Provincial Herbal Ecological Planting Engineering Technology Research Center